Predict your next investment

Kv1.3 Therapeutics company logo
HEALTHCARE | Pharmaceuticals / Drugs
kv13therapeutics.com

See what CB Insights has to offer

Stage

Debt | Alive

Total Raised

$190K

Last Raised

$170K | 4 yrs ago

About Kv1.3 Therapeutics

Kv1.3 Therapeutics is a biopharmaceutical focused on developing new treatment options for rare autoimmune diseases.

Kv1.3 Therapeutics Headquarter Location

219 Terry Ave. N. Suite 300

Auburn, Washington, 98092,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kv1.3 Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kv1.3 Therapeutics is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Kv1.3 Therapeutics Patents

Kv1.3 Therapeutics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/26/2015

1/30/2018

Autosomal recessive disorders, Rare diseases, Autoimmune diseases, Transcription factors, Syndromes

Grant

Application Date

8/26/2015

Grant Date

1/30/2018

Title

Related Topics

Autosomal recessive disorders, Rare diseases, Autoimmune diseases, Transcription factors, Syndromes

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.